IAG933   Click here for help

GtoPdb Ligand ID: 13367

Synonyms: IAG-933 | NVP-IAG933
PDB Ligand
Compound class: Synthetic organic
Comment: IAG933 is a small molecule that inhibits the protein-protein interaction (PPI) between YAP/TAZ and TEAD [1], as a route to inhibit oncogenic activation of the Hippo pathway [2]. IAG933 binds with high-affinity to the TEAD pocket (of all TEAD paralogs) that participates in formation of the YAP/TAZ-TEAD PPI.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 3
Rotatable bonds 8
Topological polar surface area 92.18
Molecular weight 529.96
XLogP 1.27
No. Lipinski's rules broken 1

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CNC(=O)C1=CN=C(C(=C1C2=C3C[C@](C4=CC=CC=C4)([C@@H]5CCCN5)OC3=CC(=C2Cl)F)F)OCCO
Isomeric SMILES CNC(=O)C1=CN=C(C(=C1C2=C3C[C@@](OC3=CC(=C2Cl)F)([C@@H]4CCCN4)C5=CC=CC=C5)F)OCCO
InChI InChI=1S/C27H26ClF2N3O4/c1-31-25(35)17-14-33-26(36-11-10-34)24(30)22(17)21-16-13-27(20-8-5-9-32-20,15-6-3-2-4-7-15)37-19(16)12-18(29)23(21)28/h2-4,6-7,12,14,20,32,34H,5,8-11,13H2,1H3,(H,31,35)/t20-,27-/m0/s1
InChI Key HUVOYQMXUNTUAI-DCFHFQCYSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

References
1. Chapeau EA, Sansregret L, Galli GG, Chène P, Wartmann M, Mourikis TP, Jaaks P, Baltschukat S, Barbosa IAM, Bauer D et al.. (2024)
Direct and selective pharmacological disruption of the YAP-TEAD interface by IAG933 inhibits Hippo-dependent and RAS-MAPK-altered cancers.
Nat Cancer, 5 (7): 1102-1120. [PMID:38565920]
2. Zhao B, Pobbati AV, Rubin BP, Stauffer S. (2023)
Leveraging Hot Spots of TEAD-Coregulator Interactions in the Design of Direct Small Molecule Protein-Protein Interaction Disruptors Targeting Hippo Pathway Signaling.
Pharmaceuticals (Basel), 16 (4). [PMID:37111340]